Bart Staels
Molecular Biology · 2000–2021
A researcher in the Science corpus: 22 papers; trusts 6 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 174 citations into it; #12,432 of 17,773 by trust here, #3,204 by citations
- Surgery — 84 citations into it
- Endocrinology, Diabetes and Metabolism — 78 citations into it
- Immunology — 57 citations into it
- Cardiology and Cardiovascular Medicine — 37 citations into it
- Neurology — 10 citations into it
Whom Bart Staels trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Bart Staels overall
Papers from Bart Staels's perspective
Ordered by how strongly the researchers Bart Staels trusts endorse each paper. Same corpus, a different order for every researcher.
- The chemokine system in diverse forms of macrophage activation and polarization. (Trends in immunology)
- Toll-like receptor–induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens (Nature Immunology)
- Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. (Molecules and Cells)
- Macrophage-specific PPARγ controls alternative activation and improves insulin resistance (Nature)
- The many faces of macrophage activation (Journal of Leukocyte Biology)
- The language of covalent histone modifications (Nature)
- The mechanisms of action of PPARs. (Annual Review of Medicine)
- Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity (Cell)
- PPARs and the complex journey to obesity (Nature Medicine)
- Cardiovascular morbidity and mortality associated with the metabolic syndrome. (Diabetes Care)
Their papers
- Sorting out the roles of PPARα in energy metabolism and vascular homeostasis (2006) — 831 citations
- Role of bile acids and bile acid receptors in metabolic regulation. (2009) — 1,650 citations
- PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. (2007) — 1,331 citations
- Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity* (2000) — 634 citations
- Therapeutic roles of peroxisome proliferator-activated receptor agonists. (2005) — 661 citations
- PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway (2001) — 904 citations
- Peroxisome proliferator-activated receptors in inflammation control. (2001) — 796 citations
- IUPHAR-DB: new receptors and tools for easy searching and visualization of pharmacological data (2010) — 112 citations
- Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. (2015) — 1,367 citations
- Macrophage subsets in atherosclerosis (2015) — 632 citations
- International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors (2006) — 1,003 citations
- PPAR control of metabolism and cardiovascular functions (2021) — 782 citations
- Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society (2021) — 742 citations
- Molecular Actions of PPARα in Lipid Metabolism and Inflammation. (2018) — 779 citations
- PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD (2017) — 685 citations
- Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening. (2016) — 918 citations
- Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652 (2016) — 1,523 citations
- Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion (2015) — 628 citations
- Macrophage phenotypes in atherosclerosis (2014) — 634 citations
- Survey of period variations of superhumps in SU UMa-type dwarf novae. X. The tenth year (2017) (2009) — 132 citations